Status:

COMPLETED

Clinical and Genetic Characterization of Individuals With Achromatopsia

Lead Sponsor:

Beacon Therapeutics

Collaborating Sponsors:

National Eye Institute (NEI)

Conditions:

Achromatopsia

Eligibility:

All Genders

6+ years

Brief Summary

The purpose of this study is to identify individuals with achromatopsia caused by mutations in the CNGB3 gene and characterize their clinical condition using several tests of visual function every 6 m...

Detailed Description

Individuals with a clinical diagnosis of achromatopsia will be asked to provide informed consent and will then have a single 5 mL blood sample drawn for DNA sequence analysis of genes known to cause a...

Eligibility Criteria

Inclusion

  • Clinical diagnosis of achromatopsia (screening portion of study);
  • Molecular confirmation of mutations in the CNGB3 gene (main portion of study);
  • At least 6 years of age;
  • Willing and able to perform study procedures;
  • Signed informed consent(s) obtained (and child assent where applicable).

Exclusion

  • Not able to have a blood sample drawn;
  • Pre-existing eye conditions that would interfere with interpretation of study endpoints (e.g. glaucoma, corneal or lenticular opacities, diabetic retinopathy, history of retinal detachment);
  • Participating in an interventional research study of drugs or devices for treatment of achromatopsia or other retinal diseases;
  • Use of medications that may impair color vision (e.g. hydroxychloroquine);
  • Any condition which leads the investigator to believe that the participant cannot comply with the protocol requirements or that may place the participant at an unacceptable risk for participation.

Key Trial Info

Start Date :

June 1 2013

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

April 1 2017

Estimated Enrollment :

56 Patients enrolled

Trial Details

Trial ID

NCT01846052

Start Date

June 1 2013

End Date

April 1 2017

Last Update

October 13 2017

Active Locations (5)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (5 locations)

1

VitreoRetinal Associates

Gainesville, Florida, United States, 32607

2

Bascom Palmer Eye Institute

Miami, Florida, United States, 33136

3

Pangere Center for Inherited Retinal Diseases, The Chicago Lighthouse for People Who Are Blind or Visually Imp

Chicago, Illinois, United States, 60608

4

Casey Eye Institute, Oregon Health & Science University

Portland, Oregon, United States, 97239

Clinical and Genetic Characterization of Individuals With Achromatopsia | DecenTrialz